An Overview of Calcium Pyrophosphate Deposition Disease (CPPD)

A Type of Arthritis Often Misdiagnosed as Gout

Calcium pyrophosphate deposition disease (CPPD) is a type of arthritis. It is caused by deposits of calcium phosphate crystals in the joints and has similar characteristics to gout. A CPPD attack can occur suddenly and cause intense pain, inflammation, and disability.

Older man suffering from knee pain
Gurpal Singh Datta / Getty Images

CPPD is known by other names including pseudogout, an older term still used in many medical practices, and chondrocalcinosis is a related term that specifically refers to the calcium deposits that develop in the cartilage of joints.


With CPPD, the progressive formation of calcium in the joints can trigger occasional flare-ups of inflammatory arthritis symptoms including pain, stiffness, swelling, fatigue, low-grade fever, and restricted movement.

The risk of CPPD tends to increase with age. According to statistics from the American College of Rheumatology, the development of calcium crystals occurs in almost 3% of adults in their 50s. That number increases to nearly 50% by the time a person reaches 90.

Not everyone who develops CPPD crystal will experience symptoms. Of the 25% who do, most will have painful episodes involving the knees or experience pain and inflammation of the ankles, elbows, hands, wrists, or shoulders. CPPD attacks can last from a few days to several weeks.

CPPD attacks may be triggered by a severe illness, surgery, trauma, or extreme overexertion. Over the course of years, the disease can cause progressive deterioration of joints, resulting in long-term disability.

Around 5% of people who have CPPD will develop a chronic rheumatoid arthritis-like condition involving peripheral joints and affecting the same joints on different sides of the body, such as the wrists or knees.


The diagnosis of CPPD is often delayed because the symptoms are commonly mistaken for more common types of arthritis, including osteoarthritis, rheumatoid arthritis, and gout (a disease characterized by the formation of uric acid crystals).

The diagnosis will usually involve the aspiration of fluid from the affected joint and analysis of the crystalline deposits in the lab.

The doctor may also order imaging tests such as an ultrasound, a ​computed tomography (CT) scan, or a magnetic resonance imaging (MRI) scan to help identify calcified masses around the joint.


Unlike gout, in which the uric acid crystals can be dissolved with medications, the crystals involved in CPPD are insoluble (meaning they are unable to be dissolved).

Treatment, therefore, is focused on alleviation of symptoms and avoidance of future attacks.

Pharmaceutical options include:

Surgery may be considered to remove a calcified mass from a joint, although it is still considered experimental, with limited data to support its use.

1 Source
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. American College of Rheumatology. Calcium pyrophosphate deposition. March 2017.

Additional Reading
  • American College of Rheumatology. "Calcium Pyrophosphate Deposition (CPPD)." Atlanta, Georgia; updated March 2017.

  • Schlee, S.; Bollheimer, L.; Bersch, T. et al. "Crystal Arthritides: Gout and Calcium Pyrophosphate Arthritis/Part 1: Epidemiology and Pathophysiology." Z Gerontol Geriatr. 2017. DOI: 10.1007/s00391-017-1197-3.

By Carol Eustice
Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis.